Vnitr Lek 2014, 60(4):271-274

Development of clinical interest on pulmonary hypertension in the Czech Republic

Pavel Jansa
Centrum pro plicní hypertenzi II. interní kliniky kardiologie a angiologie 1. LF UK a VFN Praha, přednosta prof. MUDr. Aleš Linhart, DrSc.

Development of clinical interest on the pulmonary hypertension is associated with the development of cardiac catheterization. The first measurement of cardiac output during right heart catheterization was performed by Otto Klein, who worked at the German University in Prague right after Forssmann's pioneering act. The invention of the floating balloon catheter is connected with the name of William Ganz, who was born in Košice and studied medicine in Prague. Some medical centres in Prague, known as Prague School of Pulmonary Circulation have dedicated to the issue of pulmonary hypertension since the 60s of last century. From their initiative was established the European Society of Breathing Pathophysiology and between the year 1969 and 1999 were regularly held in Prague international conferences dedicated to pulmonary circulation. In clinical practice has dominated interest on treatable forms of chronic pulmonary hypertension - pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in past 15 years. Therapy of PAH patients is concentrated in 3 specialized centres in the Czech Republic. The care of CTEPH patients is provided in Cardiocentre of General Faculty Hospital in Prague. Surgical treatment is provided to Slovak patients as well.

Keywords: chronic thromboembolic pulmonary hypertension; heart catheterization; Prague School of pulmonary circulation; pulmonary hypertension; pulmonary arterial hypertension

Received: February 9, 2014; Published: April 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jansa P. Development of clinical interest on pulmonary hypertension in the Czech Republic. Vnitr Lek. 2014;60(4):271-274.
Download citation

References

  1. Jansa P, Popelova J, Al-Hiti H et al. Chronická plicní hypertenze. Doporučený diagnostický a léčebný postup České kardiologické společnosti, 2010. Cor Vasa 2011; 53(3): 169-182. Go to original source...
  2. Riedel M. Dějiny kardiologie. Galén: Praha 2009. ISBN 9788072626144.
  3. Romberg E. Ueber Sklerose der Lungen arterie. Dtsch Archiv Klin Med 1891; 48: 197-206.
  4. Dresdale DT, Schultz M, Michtom RJ. Primary pulmonary hypertension: I. Clinical and hemodynamic study. Am J Med 1951; 11(6): 686-705. Go to original source... Go to PubMed...
  5. Chatterjee K. The Swan-Ganz catheters: past, present, and future. A viewpoint. Circulation 2009; 119(1): 147-152. Go to original source... Go to PubMed...
  6. Hatano E, Strasser T(eds). Primary pulmonary hypertension: report on a WHO meeting, Geneva, 15-17 October, 1973. World Health Organization: Geneva 1975. ISBN: 9242560448.
  7. Simonneau G, Galie N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S): S5-S12. Go to original source... Go to PubMed...
  8. Galie N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30(20): 2493-2537. Go to original source... Go to PubMed...
  9. Hoeper MM, Bogaard HJ, Condliffe R et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62(Suppl 25): D42-D50. Go to original source... Go to PubMed...
  10. Widimský J. Historie mezinárodních sympózií o plicní cirkulaci. Cor Vasa 1995; 37(1-3): K33-K37.
  11. Jansa P, Susa Z, Aschermann M. Centrum primární plicní hypertenze - naše první zkušenosti. Cor Vasa 2000; 42(10): 516-517.
  12. Jansa P, Jarkovsky J, Al-Hiti H et al. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Jansa+P%2C+Jarkovsky+J%2C+Al-Hiti+H+et+al.+Epidemiology+and+long-term+survival+of+pulmonary+arterial+hypertension+in+the+Czech" \o "BMC pulmonary medicine." BMC Pulm Med 2014; 14:45. Dostupné z DOI: <http://doi:10.1186/1471-2466-14-45>. Go to original source... Go to PubMed...
  13. Jansa P, Becvar R, Ambroz D et al. Pulmonary Arterial Hypertension Associated with Systemic Sclerosis in the Czech Republic. Clin Rheumatol 2012; 31(3): 557-561. Go to original source... Go to PubMed...
  14. Riedel M, Staněk V, Widimský J et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81(2): 151-158. Go to original source... Go to PubMed...
  15. Lindner J, Jansa P, Kunstyr J et al. Implementation of a new programme for the surgical treatment of CTEPH in the Czech Republic-Pulmonary endarterectomy. Thorac Cardiovasc Surg 2006; 54(8): 528-531. Go to original source... Go to PubMed...
  16. Reichenbach A, Al-Hiti H, Malek I et al. The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study. Int J Cardiol 2013; 168(1): 60-65. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.